Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil
Crossref DOI link: https://doi.org/10.1186/s12872-017-0584-4
Published Online: 2017-06-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freitas, Carolina Gomes
Walsh, Michael
Atallah, Álvaro Nagib
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/226186)